Protocol Ledger

NCT05257629 · Phase III · RECRUITING

Aggressive Smoking Cessation Trial (ASAP)

Interventional Phase III clinical trial protocol NCT05257629 sponsored by Sir Mortimer B. Davis - Jewish General Hospital in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-02-02 Enrollment: 798 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05257629
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)798 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05257629
Protocol FieldVerified Registry Value
NCT IdentifierNCT05257629
Consolidated Lead SponsorSir Mortimer B. Davis - Jewish General Hospital
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment798 participants (ESTIMATED)
Registered Start Date2023-02-02
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05257629
Hospital Research SiteLocationSite Profile
Sunnybrook Health Sciences CentreToronto, CanadaOpen Hospital Dossier ->
Jewish General HospitalMontreal, CanadaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI